Clinical and pathologic evaluation of serum immunoreactive human placental lactogen (IR-HPL) in abnormal pregnancy.
D000022:Abortion, Spontaneous; D001724:Birth Weight; D005314:Embryonic and Fetal Development; D004899:Erythroblastosis, Fetal; D005260:Female; D005313:Fetal Death / Q000097:blood; D005865:Gestational Age; D006453:Hemoglobinopathies / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood; D007231:Infant, Newborn; D009393:Nephritis / Q000097:blood; D009929:Organ Size; D010920:Placenta / Q000033:anatomy & histology / Q000473:pathology / Q000503:physiopathology; D010928:Placental Lactogen / Q000097:blood*; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood; D011250:Pregnancy Complications, Hematologic / Q000097:blood; D011254:Pregnancy in Diabetics / Q000097:blood; D011273:Pregnancy, Prolonged; D011863:Radioimmunoassay; D012204:Rh-Hr Blood-Group System; D013997:Time Factors
D012204:Rh-Hr Blood-Group System; D010928:Placental Lactogen